EORTC precision medicine studies deliver medical progress: leaving no one behind
What do Breast Cancer (BC) and papillary Renal Cell Carcinoma [...]
MINDACT: MammaPrint Test can reduce use of chemotherapy among early-stage Breast Cancer patients
NEW ORLEANS — Among patients with early-stage breast [...]
EORTC precision medicine study brings therapeutic progress to patients with very rare cancers
Treatment of papillary renal cell carcinoma (pRCC) remains empiric. With [...]
Watch how cancer survivors struggle to resume a normal life
On 31 March and 1 April 2016, EORTC held its [...]
An update on SPECTA
The next generation sequencing service provider for SPECTA, 14M Genomics, [...]
EUPATI launched new educational resources for patients and lay-people
Another example of EORTC concrete support to patient involvement in [...]
Pooled Health Related Quality of Life Data: large databases and partnerships demonstrate their value at improving cancer care
Started in 2008, PROBE, Patient Reported Outcome and Behavioural Evidence, [...]
EORTC-GIMEMA tackling unmet medical needs: survival benefit for elderly patients with AML
Treatment of acute myeloid leukemia (AML) in [...]
EORTC Symposium on Multidisciplinary Quality Assurance at World Cancer Congress 2016
The EORTC is hosting a Symposium on the integration of [...]
EORTC supports World Cancer Day 2016
Cancer knows no boundaries. It has, or will, affect us [...]
